These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8835110)
1. Inadequate azithromycin activity against Brucella melitensis in mice with acute or chronic infections. Domingo S; Gamazo C J Chemother; 1996 Feb; 8(1):55-8. PubMed ID: 8835110 [TBL] [Abstract][Full Text] [Related]
2. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice. Domingo S; Gastearena I; Vitas AI; López-Goñi I; Dios-Viéitez C; Díaz R; Gamazo C J Antimicrob Chemother; 1995 Oct; 36(4):647-56. PubMed ID: 8591939 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection. Atkins HS; Spencer S; Brew SD; Jenner DC; Sefton AM; MacMillan AP; Brooks TJ; Simpson AJ Int J Antimicrob Agents; 2010 Jul; 36(1):66-8. PubMed ID: 20022474 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice. Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of roxithromycin and azithromycin in experimental murine brucellosis. Lang R; Shasha B; Ifrach N; Tinman S; Rubinstein E Chemotherapy; 1994; 40(4):252-5. PubMed ID: 8082413 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection. Atkins HS; Spencer S; Brew SD; Jenner DC; Russell P; MacMillan AP; Eley SM; Simpson AJ Int J Antimicrob Agents; 2009 Nov; 34(5):474-6. PubMed ID: 19500948 [TBL] [Abstract][Full Text] [Related]
7. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin. Lang R; Shasha B; Rubinstein E Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection. Atkins HS; Spencer S; Brew SD; Laws TR; Thirlwall RE; MacMillan AP; Brooks TJ; Simpson AJ Int J Antimicrob Agents; 2009 Nov; 34(5):471-3. PubMed ID: 19682862 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice. Domingo S; Díaz R; Gamazo C FEMS Immunol Med Microbiol; 1995 Oct; 12(2):91-5. PubMed ID: 8589668 [TBL] [Abstract][Full Text] [Related]
11. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864 [TBL] [Abstract][Full Text] [Related]
12. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load. Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401 [TBL] [Abstract][Full Text] [Related]
13. Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice. N T; B N; O O; D D; J B BMC Complement Altern Med; 2018 May; 18(1):144. PubMed ID: 29724202 [TBL] [Abstract][Full Text] [Related]
14. Doxycycline-encapsulated solid lipid nanoparticles for the enhanced antibacterial potential to treat the chronic brucellosis and preventing its relapse: in vivo study. Hosseini SM; Farmany A; Abbasalipourkabir R; Soleimani Asl S; Nourian A; Arabestani MR Ann Clin Microbiol Antimicrob; 2019 Nov; 18(1):33. PubMed ID: 31706304 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey. Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728 [TBL] [Abstract][Full Text] [Related]
16. Medically treated splenic abscess due to Brucella melitensis. Yayli G; Işler M; Oyar O Scand J Infect Dis; 2002; 34(2):133-5. PubMed ID: 11928846 [TBL] [Abstract][Full Text] [Related]
18. Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study. Abo El-Ela FI; Hussein KH; El-Banna HA; Gamal A; Rouby S; Menshawy AMS; El-Nahass ES; Anwar S; Zeinhom MMA; Salem HF; Al-Sayed MAY; El-Newery HA; Shokier KAM; El-Nesr KA; Hosein HI AAPS PharmSciTech; 2020 Nov; 21(8):326. PubMed ID: 33206259 [TBL] [Abstract][Full Text] [Related]
19. The effect of long-term ethanol feeding on efficacy of doxycycline plus rifampicin in the treatment of experimental brucellosis caused by Brucella melitensis in rats. Yumuk Z; Dundar V J Chemother; 2005 Oct; 17(5):509-13. PubMed ID: 16323439 [TBL] [Abstract][Full Text] [Related]
20. Splenic abscess due to brucellosis: a case report and a review of the literature. Yilmaz M; Arslan F; Başkan O; Mert A Int J Infect Dis; 2014 Mar; 20():68-70. PubMed ID: 24433982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]